Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093.
Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093.
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25486-25493. doi: 10.1073/pnas.2013379117. Epub 2020 Sep 28.
While loss-of-function mutations in Cockayne syndrome group B protein (CSB) cause neurological diseases, this unique member of the SWI2/SNF2 family of chromatin remodelers has been broadly implicated in transcription elongation and transcription-coupled DNA damage repair, yet its mechanism remains largely elusive. Here, we use a reconstituted in vitro transcription system with purified polymerase II (Pol II) and Rad26, a yeast ortholog of CSB, to study the role of CSB in transcription elongation through nucleosome barriers. We show that CSB forms a stable complex with Pol II and acts as an ATP-dependent processivity factor that helps Pol II across a nucleosome barrier. This noncanonical mechanism is distinct from the canonical modes of chromatin remodelers that directly engage and remodel nucleosomes or transcription elongation factors that facilitate Pol II nucleosome bypass without hydrolyzing ATP. We propose a model where CSB facilitates gene expression by helping Pol II bypass chromatin obstacles while maintaining their structures.
虽然 Cockayne 综合征 B 蛋白(CSB)的失活功能突变会导致神经疾病,但作为 SWI2/SNF2 家族染色质重塑因子的独特成员,CSB 广泛参与转录延伸和转录偶联的 DNA 损伤修复,但其机制仍很大程度上难以捉摸。在这里,我们使用带有纯化聚合酶 II(Pol II)和 Rad26 的体外重建转录系统,Rad26 是 CSB 的酵母同源物,研究 CSB 在核小体障碍中的转录延伸中的作用。我们表明,CSB 与 Pol II 形成稳定的复合物,并作为一种 ATP 依赖性延伸因子,帮助 Pol II 穿过核小体障碍。这种非典型机制与直接参与和重塑核小体的典型染色质重塑因子模式不同,也与不水解 ATP 而促进 Pol II 核小体绕过的转录延伸因子不同。我们提出一个模型,即 CSB 通过帮助 Pol II 绕过染色质障碍来促进基因表达,同时保持其结构。